Partial agonism through a zinc-ion switch constructed between transmembrane domains III and VII in the tachykinin NK1 receptor

Molecular Pharmacology

Volumn 58, Issue 2, 2000, Pages 263-270

  Holst, Birgitte ^a   Elling, Christian E ^a   Schwartz, Thue W ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; INOSITOL PHOSPHATE; MEMBRANE RECEPTOR; NEUROKININ 1 RECEPTOR; PHENANTHROLINE DERIVATIVE; RHODOPSIN;

ARTICLE; BINDING AFFINITY; BINDING SITE; CHELATION; DATA ANALYSIS; LIGAND BINDING; MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; RECEPTOR AFFINITY; RECEPTOR BINDING; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 0033944938     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.2.263     Document Type: Article

References (39)

1. Albert IL, Nadassy K and Wodak SJ (1998) Analysis of zinc binding sites in protein crystal structure. Protein Sci 7:1700-1716.
2. Baldwin JM (1993) The probable arrangement of the helices in G protein-coupled receptors. EMBO J 12:1693-1703.
3. Befort K, Zilliox C, Filliol D, Yue S and Kieffer BL (1999) Constitutive activation of the delta opioid receptor by mutations in transmembrane domains III and VII. J Biol Chem 274:18574-18581.
4. Berridge MJ, Dawson MC, Downes CP, Heslop JP and Irvin RF (1983) Changes in the level of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. Biochem J 212:473-482.
5. Boyd ND, Kage R, Dumas JJ, Krause JE and Leeman SE (1996) The peptide binding site of the substance P (NK-1) receptor localized by a photoreactive analogue of substance P: Presence of a disulfide bond. Proc Natl Acad Sci USA 93:433-437.
6. Elling CE, Nielsen SM and Schwartz TW (1995) Conversion of antagonist-binding site to metal-ion site in the tachykinin Nk-1 receptor. Nature (Lond) 374:74-77.
7. Elling CE and Schwartz TW (1996) Connectivity and orientation of the seven helical bundle in the tachykinin NK-1 receptor probed by zinc site engineering. EMBO J 15:6213-6219.
8. Elling CE, Thirstrup K, Holst B and Schwartz TW (1999) Conversion of agonist site to metal-ion chelator site in the β2-adrenergic receptor. Proc Natl Acad Sci USA 96:12322-12327.
9. Engelman DM, Henderson R, McLachlan AD and Wallace BA (1980) Path of the polypeptide in bacteriorhodopsin. Proc Natl Acad Sci USA 77:2023-2027.
10. Farrens DL, Altenbach C, Yang K, Hubbell WL and Khorana HG (1996) Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science (Wash DC) 274:768-770.
11. Fong TM, Huang RC and Stader CD (1992a) Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor. J Biol Chem 267:25664-25667.
12. Fong TM, Yu H, Huang RC and Stader CD (1992b) The extracellular domain of the neurokinin-1 receptor is required for high-affinity binding of peptides. Biochemistry 31:11806-11811.
13. Gether U, Ballesteros JA, Seifert R, Sanders-Bush E, Weinstein H and Kobilka BK (1997) Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility. J Biol Chem 272:2587-2590.
14. Gether U, Johansen TE, Snider RM, Lowe JA III, Nakanishi S and Schwartz TW (1993) Different binding epitopes on the NK1 receptor for substance P and a non-peptide antagonist. Nature (Lond) 362:345-348.
15. Gether U, Lin S and Kobilka BK (1995) Fluorescent labeling of purified β2 adrenergic receptor. Evidence for ligand-specific conformational changes. J Biol Chem 270:28268-28275.
16. Hibert MF, Trumpp-Kallmeyer S, Hoflack J and Bruinvels A (1993) This is not a G protein-coupled receptor. Trends Pharmacol Sci 14:7-12.
17. Hjorth SA, Schambye HT, Greenlee WJ and Schwartz TW (1994) Identification of peptide binding residues in the extracellular domains of the AT1 receptor. J Biol Chem 269:30953-30959.
18. Holst B, Zoffmann S, Elling CE, Hjorth SA and Schwartz TW (1998) Steric hindrance mutagenesis versus alanine scan in mapping of ligand binding sites in the tachykinin NK1 receptor. Mol Pharmacol 53:166-175.
19. Kage R, Leeman SE, Krause JE, Costello CE and Boyd ND (1996) Identification of methionine as the site of covalent attachment of a P-benzoyl-phenylalanine-containing analogue of substance P on the substance P (NK-1) receptor. J Biol Chem 271:25797-25800.
20. Kenakin TP (1993) Pharmacologic Analysis of Drug-Receptor Interactions. Raven Press, New York.
21. Lefkowitz RJ, Cotecchia S, Samama PS and Costa T (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci 14:303-307.
22. Lu ZL and Hulme EC (2000) A network of conserved intramolecular contacts defines the off-state of the transmembrane switch mechanism in a seven-transmembrane receptor. J Biol Chem 275:5682-5686.
23. Perlman S, Costa-Neto CM, Miyakawa AA, Schambye HT, Hjorth SA, Paiva ACM, Rivero RA, Greelee WJ and Schwartz TW (1997) Dual agonistic and antagonistic property of nonpeptide angiotensin AT1 ligands: Susceptibility to receptor mutations. Mol Pharmacol 51:301-311.
24. 1 receptor. J Biol Chem 270:1493-1496.
25. Porter JE and Perez DM (1999) Characteristics for a salt-bridge switch mutation of the α(1b) adrenergic receptor. Altered pharmacology and rescue of constitutive activity [In Process Citation]. J Biol Chem 274:34535-34538.
26. Rosenkilde MM, Cahir M, Gether U, Hjorth SA and Schwartz TW (1994) Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding. J Biol Chem 269:28160-28164.
27. Rosenkilde MM, Kledal TN, Brauner-Osborne H and Schwartz TW (1999) Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74. J Biol Chem 274:956-961.
28. Schwartz TW (1994) Locating ligand-binding sites in 7TM receptors by protein engineering. Curr Opin Biotechnol 5:434-444.
29. Schwartz TW, Gether U, Schambye HT and Hjorth SA (1995) Molecular mechanism of action of non-peptide ligands for peptide receptors. Curr Pharmaceut Design 1:325-342.
30. Schwartz TW and Rosenkilde MM (1996) Is there a lock for all keys in 7TM receptors. Trends Pharmacol Sci 17:213-216.
31. 2-adrenoceptor and the parathyoid hormone receptor. J Biol Chem 274:17033-17041.
32. Sheikh SP, Zvyaga TA, Lichtarge O, Sakmar TP and Bourne HR (1996) Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F. Nature (Lond) 383:347-350.
33. Sieving PA (1995) Dark-light: Model for nightblindness from the human rhodopsin Gly-90-Asp mutation. Proc Natl Acad Sci USA 92:880-884.
34. Strader CD, Fong TM, Tota MR and Underwood D (1994) Structure and function of G protein-coupled receptors. Annu Rev Biochem 63:101-132.
35. Strader CD, Gaffney T, Sugg EE, Candelore MB, Keys R, Patchett AA and Dixon RAF (1991) Allele-specific activation of genetically engineered receptors. J Biol Chem 266:5-8.
36. Suryanarayana S, Daunt DA, Zastrow MV and Kobilka BK (1991) A point mutation in the seventh hydrophobic domain of the A2 adrenergic receptor increases its affinity for a family of β receptor antagonists. J Biol Chem 266:15488-15492.
37. Thirstrup K, Elling CE, Hjorth SA and Schwartz TW (1996) Construction of a high affinity zinc-switch in the K-opioid receptor. J Biol Chem 271:7875-7878.
38. Vallee BL and Auld DS (1990) Zinc coordination, function and structure of zinc enzymes and other proteins. Biochemistry 29:5647-5659.
39. Wieland K, Zuurmond HM, Krasel C, Ijzerman AP and Lohse MJ (1996) Involvement of Asn-293 in stereospecific agonist recognition and in activation of the β2-adrenergic receptor. Proc Natl Acad Sci USA 93:9276-9281.